Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Preclinical update on regulation of intracranial pressure in relation to idiopathic intracranial hypertension

Research output: Contribution to journalReviewResearchpeer-review

  1. Reference values for intracranial pressure and lumbar cerebrospinal fluid pressure: a systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  2. Long-term monitoring of intracranial pressure in freely-moving rats; impact of different physiological states

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. B waves: a systematic review of terminology, characteristics, and analysis methods

    Research output: Contribution to journalReviewResearchpeer-review

  4. Initial experience with the Codman Certas adjustable valve in the management of patients with hydrocephalus

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Intranasal ketamine for acute cluster headache attacks-Results from a proof-of-concept open-label trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Paracetamol use during pregnancy - a call for precautionary action

    Research output: Contribution to journalReviewResearchpeer-review

  3. Poor social support and loneliness in chronic headache: Prevalence and effect modifiers

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Health-related quality of life in tension-type headache: a population-based study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Elevated intracranial pressure (ICP) is observed in association with a range of brain disorders. One of these challenging disorders is idiopathic intracranial hypertension (IIH), characterized by raised ICP of unknown cause with significant morbidity and limited therapeutic options. In this review, special focus is put on the preclinical research performed in order to understand the pathophysiology behind ICP regulation and IIH. This includes cerebrospinal fluid dynamics, molecular mechanisms underlying disturbances in brain fluids leading to elevated ICP, role of obesity in IIH, development of an IIH model and ICP measurements in rodents. The review also discusses existing and new drug targets for IIH that have been evaluated in vivo.

CONCLUSIONS: ICP monitoring in rodents is challenging and different methods have been applied. Some of these methods are invasive, depend on use of anesthesia and only allow short-term monitoring. Long-term ICP recordings are needed to study IIH but existing methods are hampered by several limitations. As obesity is one of the most common risk factors for IIH, a rodent obese model has been developed that mimics some key aspects of IIH. The most commonly used drugs for IIH have been evaluated in vivo for their efficacy at lowering ICP in the existing animal models. These studies suggest these drugs, including acetazolamide, might have limited or no reducing effect on ICP. Two drug targets that can impact ICP in healthy rodents are topiramate and a glucagon-like peptide-1 receptor (GLP-1R) agonist. However, it remains to evaluate their effect in an IIH model with more precise and valid ICP monitoring system. Therefore, continued evaluation in the preclinical research with refined tools is of great importance to further understand the pathophysiology behind disorders with raised ICP and to explore new drug targets.

Original languageEnglish
JournalFluids and Barriers of the CNS
Volume16
Issue number1
Pages (from-to)16-35
Number of pages12
ISSN2045-8118
DOIs
Publication statusPublished - 2019

ID: 58902535